These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9574382)

  • 1. [Minimal invasive surgery in clinically occult breast carcinoma].
    Winzer KJ; Madeja C; Guski H; Filimonow S; Hamm B; Müller JM
    Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1215-8. PubMed ID: 9574382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The ABBI system as a possibility for evaluating non-palpable lesions].
    Winzer KJ; Filimonow S; Guski H; Bick U; Hamm B; Müller JM
    Zentralbl Chir; 1998; 123 Suppl 5():57-62. PubMed ID: 10063575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Initial experiences with the Advanced Breast Biopsy Instrumentation (ABBI), a system for stereotactic excision of non-palpable breast lesions].
    Oertli D; Zuber M; Müller D; Marti WR; Köchli OR; Torhorst J; Harder F
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():379-83. PubMed ID: 9931645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Stereotactic tumor biopsy and tumor excision].
    Winzer KJ; Filimonow S; Guski H; Hamm B; Müller JM
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():374-8. PubMed ID: 9931644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of multiparametric magnetic resonance imaging of the breast for the differentiation of fat necrosis and tumor recurrence after breast-conserving surgery: A case report.
    Dörner J; Malter W; Markiefka B; Krug KB
    Rofo; 2018 Feb; 190(2):175-177. PubMed ID: 29179239
    [No Abstract]   [Full Text] [Related]  

  • 6. [Early experience with the advanced breast biopsy instrumentation system in a multicentre study].
    Kwasny W; Tausch C; Haid A; Stierer M; Konstantiniuk P; Wayand U; Sevelda P
    Gynakol Geburtshilfliche Rundsch; 2002; 42(4):212-6. PubMed ID: 12373025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New methods for minimal invasive assessment of uncertain mammography and MRI tomography findings].
    Heywang-Köbrunner SH; Smolny T; Schaumlöffel U; Heinig A; Buchmann J; Lampe D
    Zentralbl Chir; 1998; 123 Suppl 5():66-9. PubMed ID: 10063577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local tumor recurrence following breast-conservation therapy: correlation of histopathologic findings with detection method and mammographic findings.
    Giess CS; Keating DM; Osborne MP; Rosenblatt R
    Radiology; 1999 Sep; 212(3):829-35. PubMed ID: 10478253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Advanced Breast Biopsy Instrumentation (ABBI), a system for stereotactic excision of mammographically suspect nonpalpable findings in the breast].
    Oertli D; Zuber M; Müller D; Marti WR; Köchli OR; Torhorst J; Harder F
    Schweiz Med Wochenschr; 1998 May; 128(21):811-6. PubMed ID: 9642747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent carcinoma after breast conservation: diagnosis with stereotaxic core biopsy.
    Liberman L; Dershaw DD; Durfee S; Abramson AF; Cohen MA; Hann LE; Rosen PP
    Radiology; 1995 Dec; 197(3):735-8. PubMed ID: 7480747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of microcalcifications that develop at the lumpectomy site after breast-conserving therapy.
    Vora SA; Wazer DE; Homer MJ
    Radiology; 1997 Jun; 203(3):667-71. PubMed ID: 9169686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The advanced breast biopsy instrumentation (ABBI) experience at a community hospital.
    Sheth D; Wesen CA; Schroder D; Boccaccio JE; Lloyd LR
    Am Surg; 1999 Aug; 65(8):726-9; discussion 729-30. PubMed ID: 10432081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three years of experience with advanced breast biopsy instrumentation (ABBI).
    Haj M; Kniaz D; Eitan A; Solomon V; Cohen I; Loberant N
    Breast J; 2002; 8(5):275-80. PubMed ID: 12199754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal carcinoma in situ.
    Loring L; Dershaw DD
    Crit Rev Diagn Imaging; 1997 Dec; 38(6):501-33. PubMed ID: 9442977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duct carcinoma in situ: biological implications for clinical practice.
    Lagios MD
    Semin Oncol; 1996 Feb; 23(1 Suppl 2):6-11. PubMed ID: 8614847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgery for early and minimally invasive breast cancer.
    Graves TA; Bland KI
    Curr Opin Oncol; 1996 Nov; 8(6):468-77. PubMed ID: 8971466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies on the management of high-risk lesions at core biopsy from a radiology/pathology perspective.
    Georgian-Smith D; Lawton TJ
    Radiol Clin North Am; 2010 Sep; 48(5):999-1012. PubMed ID: 20868897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of percutaneous excision followed by ablation for local control in breast cancer.
    Klimberg VS; Boneti C; Adkins LL; Smith M; Siegel E; Zharov V; Ferguson S; Henry-Tillman R; Badgwell B; Korourian S
    Ann Surg Oncol; 2011 Oct; 18(11):3079-87. PubMed ID: 21904959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of stereotactic guidance of breast excisional biopsy versus stereotactic core biopsy in occult breast lesions].
    Wolf G; Helbich T
    Wien Med Wochenschr; 1998; 148(14):316-20. PubMed ID: 9816641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer recurrence following radioguided seed localization and standard wire localization of nonpalpable invasive and in situ breast cancers: 5-Year follow-up from a randomized controlled trial.
    Fung F; Cornacchi SD; Reedijk M; Hodgson N; Goldsmith CH; McCready D; Gohla G; Boylan C; Lovrics PJ
    Am J Surg; 2017 Apr; 213(4):798-804. PubMed ID: 27810132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.